Blog
909 Articles

Testing a Drug that Works Only in the Tumor Microenvironment
Scientists are trying a new type of drug combination that gets activated only in the unique conditions of the tumor microenvironment.

COVID-19 and Pancreatic Cancer Clinical Trials
How is the COVID-19 pandemic affecting clinical trials? Learn more about what steps are being taken to protect patients on trials, plus more.

Targeting Mutant KRAS with Immunotherapy
Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.

Cancer and COVID-19 Resources in One Place
AstraZeneca has created web pages that link to information and COVID-19 resources for people facing cancer or chronic diseases during the pandemic.

Oncologists Are Struggling to Treat Cancer Patients Amid the Pandemic
Dr. Allyson Ocean explains the changes to her practice and risks she and her patients face as they battle cancer amid the COVID-19 pandemic.

Be Prepared: Putting Together an Emergency Preparedness Kit
Anne Ireland outlines the important things a cancer patient should keep in an emergency preparedness kit in case of natural disaster or pandemic.

Masks On: Prevent COVID-19 Spread
The CDC recommends that everyone wear cloth masks or coverings over their mouths and noses when out in public, to prevent the spread of COVID-19.

Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.

Combining Two Drugs with Different Approaches to Enhance Treatment
A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.

Pancreatic Cancer Treatment During the COVID-19 Pandemic
During the March 2020 PancChat, pancreatic cancer experts discussed treatment during the COVID-19 pandemic, along with other important issues for patients.

Challenge Grant Recipients Moving Forward
The Pancreatic Cancer Collective awarded four teams a second round of New Therapies Challenge Grants, to further develop new pancreatic cancer treatment.